IL6 and rheumatoid arthritis: It has been shown that their combination therapy can suppress TNF-α, IL-1, IL-6, COX1, COX2, and NK-KB expressions in RA synovial tissues, thus reducing inflammation and improving the patient's condition [22, 23].